Viemed Healthcare (VMD) Equity Income (2019 - 2024)

Viemed Healthcare (VMD) has reported Equity Income for 6 consecutive years, with $96000.0 the latest figure, recorded in Q3 2024.

• For the quarter ending Q3 2024, Equity Income fell 64.44% year-over-year to $96000.0; the trailing twelve-month figure through Jun 2025 stood at $96000.0 (up 113.03% YoY), and the FY2024 full-year result was -$954000.0, down 296.7% from the prior year.
• Equity Income rose to $96000.0 in Q3 2024 per VMD's latest filing, from -$1.1 million in the prior quarter.
• Across five years, Equity Income topped out at $459000.0 in Q4 2021 and bottomed at -$1.1 million in Q2 2024.
• Historically, Equity Income has averaged $94631.6 across 5 years, with a median of $84000.0 in 2022.
• The sharpest annual moves came in 2021 and 2024: Equity Income jumped 1476.19% in 2021, then sank 915.33% in 2024.
• Over 5 years, Equity Income stood at $55000.0 in 2020, then jumped by 734.55% to $459000.0 in 2021, then plunged by 82.14% to $82000.0 in 2022, then tumbled by 47.56% to $43000.0 in 2023, then surged by 123.26% to $96000.0 in 2024.
• According to Business Quant data, Equity Income over the past three periods registered $96000.0, -$1.1 million, and $67000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.